SKYE BIOSCIENCE INC | SCHEDULE 13D/A: Others
SKYE BIOSCIENCE INC | 4: Statement of changes in beneficial ownership of securities-Officer Diep Tuan Tu
SKYE BIOSCIENCE INC | 4: Statement of changes in beneficial ownership of securities-Officer ARSENAULT KAITLYN
SKYE BIOSCIENCE INC | 4: Statement of changes in beneficial ownership of securities-Officer DHILLON PUNIT
SKYE BIOSCIENCE INC | 4: Statement of changes in beneficial ownership of securities-Director Grayson Paul A.
SKYE BIOSCIENCE INC | 144: Notice of proposed sale of securities pursuant to Rule 144
SKYE BIOSCIENCE INC | 144: Notice of proposed sale of securities pursuant to Rule 144
SKYE BIOSCIENCE INC | 144: Notice of proposed sale of securities pursuant to Rule 144
SKYE BIOSCIENCE INC | 144: Notice of proposed sale of securities pursuant to Rule 144
SKYE BIOSCIENCE INC | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Janus Henderson Group plc(0.0%),Janus Henderson Biotech Innovation Master Fund Ltd(0.0%)
SKYE BIOSCIENCE INC | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Altium Capital Management, LP EIN:(4.3%),Altium Growth Fund, LP EIN:(4.3%), etc.
SKYE BIOSCIENCE INC | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
SKYE BIOSCIENCE INC | 10-Q: Q3 2024 Earnings Report
SKYE BIOSCIENCE INC | 8-K: Skye Bioscience Reports Third Quarter 2024 Financial Results and Recent Highlights
SKYE BIOSCIENCE INC | 4: Statement of changes in beneficial ownership of securities-Officer Diep Tuan Tu
SKYE BIOSCIENCE INC | 4: Statement of changes in beneficial ownership of securities-Officer ARSENAULT KAITLYN
SKYE BIOSCIENCE INC | 4: Statement of changes in beneficial ownership of securities-Officer DHILLON PUNIT
SKYE BIOSCIENCE INC | 4: Statement of changes in beneficial ownership of securities-Director Schwab Andrew J.
SKYE BIOSCIENCE INC | 4: Statement of changes in beneficial ownership of securities-Director Grayson Paul A.
SKYE BIOSCIENCE INC | 4: Statement of changes in beneficial ownership of securities-Director Smith Karen L.
No Data